Serologic Immunity to Hepatitis A and B in US Adults and High-Risk Populations
Listen to this summary
The authors aimed to estimate the prevalence and factors associated with serologic immunity to hepatitis A (HAV) and hepatitis B (HBV) among US adults, particularly in high-risk populations. The study found that overall immunity levels were suboptimal, with 39.5% for HAV and 27.1% for HBV, highlighting significant gaps in protection, especially among high-risk groups. These results underscore the need for targeted vaccination strategies to improve immunity against these viral infections.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from JAMA internal medicine
View all →Sep 21, 2026 · JAMA internal medicine
Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma
Sep 14, 2026 · JAMA internal medicine
Effective Palliative Care for Hospice Transitions
Sep 8, 2026 · JAMA internal medicine
Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor Symptoms
Sep 8, 2026 · JAMA internal medicine
Timing of Initiation of Methadone Take-Home Dosing
Aug 31, 2026 · JAMA internal medicine
Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes
Aug 30, 2026 · JAMA internal medicine
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


